488 related articles for article (PubMed ID: 29860716)
21. Pheochromocytoma associated with adrenocortical tumor in the same gland. Two case reports and literature review.
Cotesta D; Petramala L; Serra V; Giustini S; Divona L; Calvieri S; De Toma G; Ciardi A; Corsi A; Massa R; Reale MG; Letizia C
Minerva Endocrinol; 2006 Jun; 31(2):183-9. PubMed ID: 16682942
[TBL] [Abstract][Full Text] [Related]
22. I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
Grassi I; Nanni C; Vicennati V; Castellucci P; Allegri V; Montini GC; Pagotto U; di Dalmazi G; Pasquali R; Fanti S
Clin Nucl Med; 2011 Feb; 36(2):124-6. PubMed ID: 21220975
[TBL] [Abstract][Full Text] [Related]
23. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II.
De Graaf JS; Dullaart RP; Kok T; Piers DA; Zwierstra RP
Eur J Surg; 2000 Apr; 166(4):289-92. PubMed ID: 10817323
[TBL] [Abstract][Full Text] [Related]
24. Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma.
Meyer-Rochow GY; Smith JM; Richardson AL; Marsh DJ; Sidhu SB; Robinson BG; Benn DE
J Surg Res; 2009 Nov; 157(1):55-62. PubMed ID: 19215943
[TBL] [Abstract][Full Text] [Related]
25. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma.
Greenblatt DY; Shenker Y; Chen H
Ann Surg Oncol; 2008 Mar; 15(3):900-5. PubMed ID: 18193324
[TBL] [Abstract][Full Text] [Related]
26. Genetic status determines
Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398
[TBL] [Abstract][Full Text] [Related]
27. Pheochromocytoma in multiple endocrine neoplasia type 2A: positive 123I MIBG with negative CT and equivocal 131I MIBG imaging.
Ishii S; Shishido F; Miyajima M; Sakuma K; Kikuchi K
Clin Nucl Med; 2012 Jun; 37(6):596-8. PubMed ID: 22614196
[TBL] [Abstract][Full Text] [Related]
28. [Bilateral adrenal pheochromocytoma. A case report].
Benchekroun A; Lachkar A; Soumana A; Farih MH; Belahnech Z; Marzouk M; Faik M
Ann Urol (Paris); 1998; 32(5):274-8. PubMed ID: 9827197
[TBL] [Abstract][Full Text] [Related]
29. Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?
Miskulin J; Shulkin BL; Doherty GM; Sisson JC; Burney RE; Gauger PG
Surgery; 2003 Dec; 134(6):918-22; discussion 922-3. PubMed ID: 14668723
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Lugat A; Drui D; Mirallié E; Kraeber-Bodéré F; Ansquer C
Clin Nucl Med; 2019 Sep; 44(9):738-740. PubMed ID: 31306205
[TBL] [Abstract][Full Text] [Related]
31. 123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma.
Cuenca-Cuenca JI; Marín-Oyaga VA; Borrego-Dorado I; Navarro-González E; Martos-Martínez JM; Vázquez-Albertino R
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):263-5. PubMed ID: 23434017
[TBL] [Abstract][Full Text] [Related]
32. [Severe arterial hypertension and pheochromocytoma in childhood. Case report and review of the literature].
Laporte R; Godart F; Brevière GM; Vaksmann G; Francart C; Rey C
Arch Mal Coeur Vaiss; 2000 May; 93(5):627-30. PubMed ID: 10858862
[TBL] [Abstract][Full Text] [Related]
33. Detecting pheochromocytoma: defining the most sensitive test.
Guller U; Turek J; Eubanks S; Delong ER; Oertli D; Feldman JM
Ann Surg; 2006 Jan; 243(1):102-7. PubMed ID: 16371743
[TBL] [Abstract][Full Text] [Related]
34. A diagnostic dilemma in diagnosing and managing an incidental phaeochromocytoma.
Tahrani AA; Macleod AF
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):204-7. PubMed ID: 16705554
[TBL] [Abstract][Full Text] [Related]
35. [Bilateral pheochromocytomas with von Hippel-Lindau disease: a case report].
Masunaga K; Inadome A; Sugiyama Y; Maeda Y; Satoji Y; Takahashi W; Yoshida M; Ueda S; Ikeda K; Takano Y; Yatsuda J
Nihon Hinyokika Gakkai Zasshi; 2007 Nov; 98(7):843-7. PubMed ID: 18062217
[TBL] [Abstract][Full Text] [Related]
36. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F
Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography with 18F-fluorodeoxyglucose is a useful tool for the diagnosis of pheochromocytomas without distant metastasis, where malignancy is suspected on the basis of histopathologic analysis.
Kikuchi F; Imachi H; Murao K; Ohyama T; Miyai Y; Kushida Y; Haba R; Kakehi Y; Ishida T
Am J Med Sci; 2010 Aug; 340(2):160-3. PubMed ID: 20693835
[TBL] [Abstract][Full Text] [Related]
38. [Personal experience in diagnosis and localization of pheochromocytoma].
Andjelković Z; Tavcar I
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
[TBL] [Abstract][Full Text] [Related]
39. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of pheochromocytoma.
Lenz T; Gossmann J; Schulte KL; Salewski L; Geiger H
Clin Lab; 2002; 48(1-2):5-18. PubMed ID: 11833676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
